Cellectar BioSciences Inc.

11/01/2024 | Press release | Distributed by Public on 11/01/2024 15:16

Material Event Form 8 K

Item 8.01. Other Events.

On November 1, 2024, the Company issued a press release announcing that it had received a letter from Nasdaq, Inc. informing the Company that it had regained compliance with Nasdaq Listing Rule 5250(c)(1). A copy of the press release is furnished as Exhibit 99.1 and is incorporated by reference herein.